Abstract 13200: Relationship Between Baseline Low-Density Lipoprotein Cholesterol and Percent Low-Density Lipoprotein Cholesterol Reduction With Evolocumab in the FOURIER (Further Cardiovascular Outcomes Research With PCSK9 Inhibition in Patients With Elevated Risk) Trial

Dan P Marcusa,Robert P Giugliano,Jeong-Gun Park,Peter Sever,Huei Wang,Andrew Hamer,Terje R Pedersen,Anthony C Keech,Marc S Sabatine

Circulation（2020）

引用 0|浏览4

暂无评分

摘要

Introduction: The FOURIER trial demonstrated that the PCSK9 inhibitor evolocumab robustly reduced LDL-C amongst patients on moderate or high intensity statins. We investigated whether the magnitude...

查看译文

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要